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Abstract
Caudal type homeobox gene-1 and -2 (CDX-1 and CDX-2), homologues of the Drosophila homeobox gene caudal, encode
transcription factors in endoderm derived tissues of the intestine. CDX genes control proliferation and differentiation of
intestinal mucosal cells and colon cancer cells. Hirschsprung’s Disease (HD) or congenital intestinal aganglionosis, a major
developmental anomaly of intestine, which causes functional intestinal obstruction, is frequently associated with
enterocolitis. Aetiology of HD-associated enterocolitis (HDEC) remains obscure. Reduction of gut mucosal enteroendocrine
cells, and inefficient transfer of the secretory immunoglobulin A across the gut mucosal cell were shown to be associated with
enterocolitis in HD patients suggesting that mucosa may directly involve in the pathophysiology of HDEC. This study aims
to ascertain whether the CDX-1 and CDX-2 genes, that control the proliferation and differentiation of mucosal cells, play a
role in HDEC. Using semi-quantitative reverse transcription^polymerase chain reaction (RT^PCR) and in situ hybridisation,
we analysed the expression of CDX-1 and CDX-2 genes in colon specimens of normal controls, necrotising enterocolitis
(NEC) infants, and HD patients with and without enterocolitis. We showed for the first time that CDX-1 and CDX-2 genes
were expressed in the colonic mucosal epithelium in normal, NEC and in HD infants. However, the expressions of both genes
were reduced in patients with HDEC. Our findings suggest that reduced expression of CDX-1 and CDX-2 genes in mucosa
may be associated with the development of HDEC. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
CDX-1 and CDX-2, members of the caudal-type
homeobox gene family, are transcription factors that
are expressed early in the intestines of human and
rodent [1]. Cdx-2 mRNA was ¢rst detectable in en-
doderm and mesenchyme at the posterior gut in 8.5
days post coitum (d.p.c.) mouse embryos and was
then progressively con¢ned to the intestinal endo-
derm. Temporal and spatial expression patterns of
Cdx-2 in the small intestine and colon parallel the
morphogenesis of the de¢nitive intestine [2]. The ex-
pression pro¢le of Cdx-1 mRNA was di¡erent from
Cdx-2 in that it was not detected until 14 d.p.c.
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where it could be found in the endoderm of the de-
veloping gut [3^5]. In the intestinal epithelium, Cdx-1
mRNA and protein were essentially con¢ned to the
crypts, but Cdx-2 mRNA and protein showed com-
plex di¡erential distributions. In the small intestine
and distal colon, Cdx-2 mRNA was found predom-
inantly in the crypts. However, the protein was most
abundant in the di¡erentiated cells that had already
migrated up to the tip of the crypts. In the proximal
colon, Cdx-2 mRNA and protein were evenly distrib-
uted from the bottom of the crypts to the di¡erenti-
ated epithelial cells at the tip. In mutant animal anal-
ysis, it was found that homozygous Cdx-1 and
heterozygous Cdx-2 knockout mice frequently devel-
op dysplastic lesions, metaplasia and homeotic trans-
formation of endoderm to a rostral phenotype in the
colon [6^9]. Therefore, Cdx-1 and Cdx-2 genes have
been suggested to be involved in the regulation of the
proliferation and di¡erentiation of intestinal epithe-
lial cells [7,10,11].
In human small intestine and colon, CDX-1 pro-
tein was localised in the nuclei of epithelial cells.
Reduced levels of CDX-1 and CDX-2 mRNA were
reported in colorectal cancer using reverse transcrip-
tion^polymerase chain reaction (RT^PCR) and
Northern blot analysis in human [5,12]. Truncating
mutation of CDX-2 genes was reported in human
colorectal cancers [11,13,14]. CDX-1 protein was
shown to inhibit the proliferation of rat intestinal
epithelial cells IEC6 by down-regulation of cyclin-D
[15]. Cdx-1 is the direct transcriptional target of the
Wnt signalling pathway [16], and Wnt signalling in
gut requires the binding of the Tcf4/L-catenin com-
plex to the Cdx-1 gene promoter, which induces the
expression of Cdx-1. Abnormal Wnt and L-catenin
signalling has been implicated in the carcinogenesis
in colon of carcinomas, hepatocellular carcinomas
and melanomas [17,18]. These ¢ndings are in line
with the regulatory role of CDX-1 and CDX-2 in
cellular proliferation, di¡erentiation.
Hirschsprung’s disease (HD), a major anomaly of
the enteric nervous system (ENS), is characterised by
the absence of intramural ganglion cells and the pres-
ence of hypertrophic nerve trunks in the distal intes-
tine that results in functional intestinal obstruction.
The pathogenesis of HD remains poorly understood.
Recent studies of HD showed that the RET, GDNF,
EDN3, EDNRB and SOX10 genes were implicated in
HD and mutations in these genes accounted for
about 20% of the patients [19]. Enterocolitis is a
serious complication of HD with a variable incidence
of 6^58% and remains the major cause of morbidity
and mortality in patients with HD [20,21]. Histolog-
ically, it is characterised by an acute in£ammatory
in¢ltrate into the crypts and mucosa of the intestinal
epithelium in both the aganglionic and ganglionic
segments. Speculation on the aetiology of HD-asso-
ciated enterocolitis (HDEC) includes colonic stasis
resulting from functional intestinal obstruction [22],
bacteria infection [23], mucosal ischaemia [24], de-
fects in the amount of immunoglobulin A [25] and
hypersensitivity reaction [26], enteroendocrine cell
de¢ciency [27]. Piebald-lethal mouse, a mouse model
of HD, has missense mutations in the ednrb genes
and frequently develops systemic sepsis caused by
enteric organism [28,29]. It has been postulated that
the loss of mucosal barrier integrity in the distal
aganglionic bowel allows the translocation of enteric
organism and causes systemic sepsis in piebald-lethal
mouse. Intestinal mucosal epithelium is continuously
renewed and replenished from stem cells that are
located in intestinal crypts. Renewal and replenishing
of mucosal epithelial cells is essential for the intestine
to repair damage of mucosa and prevent bacterial
infection and in£ammation. Therefore, loss of mu-
cosal integrity as a consequence of defective renewal
and replenish of stem cells could be an initial event in
the development of enterocolitis. While HD may be
caused by mutations in a variety of genes, at present
it is not clear whether there is a common molecular
basis for HD-associated enterocolitis. We hypo-
thesise that the CDX genes may be involved in
maintaining the integrity of the intestinal epithelium
by direct involvement in the control of epithelial cell
proliferation and di¡erentiation. In this study, we
aim to determine whether CDX-1 and CDX-2 genes
are involved in the pathology of HD-associated
enterocolitis by investigating the tissue-speci¢c pat-
tern of the distribution of CDX-1 and CDX-2
transcripts in colon from non-HD and HD patients
with and without enterocolitis. In this study, we
show that the CDX-1 and CDX-2 genes are ex-
pressed in the epithelium of normal colon, and fur-
ther provide the ¢rst evidence that reduced expres-
sion of these genes is associated with HD-associated
enterocolitis.
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2. Materials and methods
2.1. Tissue preparation for RNA extraction and
sections
Resected specimens of colon were collected from
11 HD patients and analysis of the rectal biopsy
samples of these patients revealed an absence of gan-
glion cell. Haematoxylin^eosin staining, acetylcholin-
esterase histochemical staining on rectal biopsies of
patients with HD performed by pathologists con-
¢rmed the diagnosis of HD in all eleven patients.
The clinical diagnosis of enterocolitis was made on
the basis of the presentation of diarrhea, fever and
an distended abdomen. Age- and site-matched speci-
mens of the distal colon from 12 non-HD patients
(imperforate anus, n = 5; rectal stricture, n = 1; mes-
enteric cysts, n = 1; necrotising enterocolitis, n = 5)
were included as controls. Control specimens were
obtained from normal colon proximal to and well
away from the diseased bowel; histology analysis
of control specimens con¢rmed no dysganglionosis.
Con¢rmation of enterocolitis in both patients with
HD and those with necrotising enterocolitis (NEC)
patients were made by histological analysis of re-
sected bowels. Full-thickness specimens from the
aganglionic, hypoganglionic and normoganglionic
zones of bowel of each patient and the colons of
normal controls were used for RNA extraction using
Trizol (Life Technologies, Rockville, MD). For tis-
sue sections, the specimens were ¢xed in 4% para-
formaldehyde/PBS (phosphate-bu¡ered saline; pH
7.2) and embedded in para⁄n. Sections (6 Wm thick-
ness) were prepared on microtome and mounted
onto 3-aminopropyl-triethoxy-silane (Sigma) coated
slides, dried and baked at 60‡C for 1 h.
2.2. Semi-quantitative RT^PCR analysis
Two Wg of total RNA was applied for the synthe-
sis of ¢rst strand cDNA using oligo(dT) and random
hexamers as reverse primers (SuperScript Preampli¢-
cation System, Life Technologies). Expressions of
CDX-1, CDX-2 and L-actin genes were analysed us-
ing the PCR. PCR was performed in 50 Wl of stan-
dard bu¡er containing primers (0.2 WM each), 2 Wl of
cDNA, 0.5 unit of AmpliTaq DNA polymerase (Life
Technologies), MgCl2 (3 mM), and dNTP (0.2 mM).
Dimethyl sulphoxide (0.5%; v/v) was added to the
reaction for the PCR of CDX-1 and CDX-2. After
the initial denaturation process at 94‡C for 3 min,
PCR was performed for 30 and 35 cycles for L-actin
gene and CDX genes, respectively, as follows: 1 min
denaturation at 94‡C; 1 min annealing (68‡C for
CDX-1 and L-actin, 70‡C for CDX-2); 1 min exten-
sion at 72‡C for each cycle. A ¢nal extension for
10 min at 72‡C was added. As controls, PCRs were
performed with the same set of RNAs but without
the addition of reverse transcriptase to test for ge-
nomic contamination. Details of primers used for
RT^PCR are shown in Table 1. Nucleotide positions
of forward and reverse primers of CDX-1, CDX-2
and L-actin genes were numbered according to their
mRNA sequences [11,12,30]. RT^PCR reactions of
each sample were performed in duplicates. One-¢fth
of the PCR products was analysed by electrophoresis
in a 2% agarose gel. Intensities of PCR bands were
quanti¢ed and relative expression levels of CDX-1
and CDX-2 to L-actin were determined using the
comparative method as described by Nicoletti and
Sassy-Prigeut [31]. Means and standard error of the
mean (S.E.M.) of the relative expression of CDX-1
and CDX-2 were determined for each group. Un-
Table 1
Primer sets for CDX-1, CDX-2 and L-actin genes
Gene Primer sequence (5P^3P) Nucleotide position Annealing temp. (‡C)
CDX-1 F, AGG ACA AGT ACC GCG TGGTCT A 553^1106 68
R, CCT CTG AAC GTA TGG AGG AGG A
CDX-2 F, GAA CCT GTG CGA GTG GAT GCG 275^941 70
R, GGT CTA TGG CTG TTGG GTG GGA G
L-actin F, CCT CGC CTT TGC CGA TCC 8^618 68
R, GGA TCT TGA GGT AGT CAG TC
Nucleotide sequences of forward primers (F) and reverse primers (R) are shown.
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paired t-test was performed to evaluate the signi¢-
cance of the di¡erences between the relative expres-
sion levels of CDX-1 and CDX-2 in controls, NEC
and various segments of patients with HD. The two-
tailed P values of the comparison between the rela-
tive expression level of CDX genes of various groups
were determined and di¡erence was considered to be
signi¢cant if the P value was less than 0.05.
2.3. Cloning of CDX-1 and CDX-2
RT^PCR products of CDX-1 and CDX-2 gene
were cloned in pGEM-T Easy Vector (Promega).
Nucleotide sequences of CDX-1 and CDX-2 clones
were determined by Sanger’s dideoxy chain termina-
tion method [32] using T7 sequencing kit (Amersham
Pharmacia Biotech).
2.4. Immunohistochemistry
The endogenous peroxidase activity was blocked
by incubation in 3% H2O2 for 10 min. Antigen re-
trieval was performed by heating the slides in 10 mM
citrate bu¡er (pH 6.0) at 95‡C for 10 min. The sec-
tions were treated and incubated with primary and
HRP-conjugated secondary antibodies. Anti-S100
(Clone 4C4.9; NeoMarkers; 1:100 dilution), and
anti-Ret R5 (Nagoya University; 1:100 dilution)
were used in this study. Negative controls were in-
cluded in which the primary antibody was omitted.
Antibody incubations were performed in PBST
(PBS+0.1% Tween 20), supplemented with 10%
horse serum. Primary antibody was incubated with
sections at 4‡C for 16 h. Incubation of secondary
antibody was performed at 37‡C for 1 h. Signals
were visualised using strepABComplex/HRP kit
(Dako) and 3,3P-diaminobenzidine tetrahydrochlo-
ride (Sigma, UK). Sections were counterstained
with haematoxylin, dehydrated, cleared in xylene
and mounted in DPX mountant (BDH).
2.5. In situ hybridisation analysis
Single-stranded [35S]UTP-labelled sense and anti-
sense riboprobes were generated from linearised
CDX-1 and CDX-2 clones. Synthesis of riboprobes,
hybridisation, autoradiography and histological
staining were performed as described previously
[33]. In situ slides were exposed for 21 days. Photo-
graphs of in situ hybridisation were taken on an
Axioplan 2 microscope (Carl Zeiss) ¢tted with a
Sony digital camera under dark-¢eld or bright-¢eld
illumination.
3. Results
3.1. Diagnosis of controls and HD patients
Using anti-Ret and anti-S100 antibodies, we
Fig. 1. S100 immunostaining of aganglionic colon of patient
with HD. S100-immunoreactive thick nerve bundle is localised
in the myenteric plexus. lm, longitudinal muscle; cm, circular
muscle. Scale bar = 100 Wm.
C
Fig. 2. Histological analysis of colon sections of non-HD control infants, infants with necrotising enterocolitis (NEC) and patients
with HD. In the colon of a non-HD control infant (A), crypts are long and intact with no obvious enlargement. In a patient with
NEC (B), the crypts are shorter but intact, and are slightly enlarged. Mucosal ulceration and lymphocytes in¢ltration in crypts (un-
¢lled arrowhead) are noted in NEC samples (C,D). In HD patients with enterocolitis, slightly enlarged crypts (black arrowhead) in hy-
poganglionic colon of patient 4421 (E) and heavily enlarged crypts (black arrowhead) in the normoganglionic colon of patient 8117
(G) are frequently observed. Lymphocyte in¢ltration (white arrowhead) in the crypt is also noted in the aganglionic colon of patient
4421 (F) and in the normoganglionic colon of patient 8117 (G). Epithelial linings are severely damaged and disappeared in the agan-
glionic colon of patients 4421 (F) and 8117 (H). Lymphocytes are frequently found in the crypts (white arrowhead) and papilla (un-
¢lled arrowhead). Scale bars: A,B,E,G,H = 100 Wm; C,D,F = 50 Wm.
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showed in the aganglionic segment the absence of
Ret immunopositive neuron (data not shown) and
the presence of S100-immunopositive hypertrophic
nerve trunks in the myenteric plexus which are typ-
ical features of aganglionic bowel of patients with
HD (Fig. 1). The diagnosis was also con¢rmed by
histochemical staining for acetylcholinesterase that
showed intense staining in HD diseased colons
(data not shown). The degrees of enterocolitis were
graded in controls and all eleven patients with HD
according to the histological grading system of
Teitelbaum et al. [34]. In the control subjects without
enterocolitis, no crypt dilation and cryptitis (grade 0)
were found in the mucosa (Fig. 2A). In the controls
with necrotising enterocolitis (NEC), slight dilated
crypts were infrequently observed (grade I) and mu-
cosa appeared shorter with intact epithelium in two
NEC samples (Fig. 2B and data not shown), ulcer-
ation of mucosa with in¢ltrated lymphocytes were
observed in three other NEC samples (grade IV)
(Fig. 2C,D and data not shown). Diagnosis and clin-
ical history of the controls and patients with HD
are shown in Table 2. Among the 11 patients with
HD, no remarkable changes were observed between
segments of colon in the seven patients without
enterocolitis, and specimens were graded as either
grade 0 or grade I (data not shown). In the remain-
ing four patients, various degrees of enterocolitis
were observed in the specimens. In one patient,
the majority of crypts showed dilation with mucin
retention (grade II) while isolated crypt abscesses
were observed in the aganglionic segment (Fig.
2E,F). In another three patients, severe dilated crypt
and multiple crypt abscesses (grade IV) were fre-
quently observed in the hypoganglionic segment
(Fig. 2G and data not shown). Mucosal ulceration
and in¢ltrated lymphocytes into the lamina propria
and crypt lumen (grade IV) were commonly found in
the aganglionic segment (Fig. 2H and data not
shown).
Table 2
Clinical data of the patients with HD and control
Case no. Age Diagnosis Colostomy
Control 5499 1 month Rectal stricture +
5918 4 months Imperforate anus +
6641 12 months Imperforate anus +
NC1 72 months Mesenteric cysts 3
B206 2 days Imperforate anus 3
B240 2.3 months Imperforate anus 3
6665 30 months Imperforate anus +
NEC 6775 4 months Necrotising enterocolitis (grade I) +
6763 12 months Necrotising enterocolitis (grade I) +
B238 9 days Necrotising enterocolitis (grade IV) 3
B231 16 days Necrotising enterocolitis (grade IV) 3
B230 5 days Necrotising enterocolitis (grade IV) 3
HD 4554 4 days Short HD +
4668 8 days Short HD +
4845 24 days Short HD 3
5585 30 days Short HD +
6297 30 days Rectal HD 3
B211 2.5 months Short HD +
B241 2 months Short HD +
HDEC 8117 1 days Short HD, enterocolitis (grade IV) +
4421 18 days Short HD, enterocolitis (grade II) +
8444 24 days Short HD, enterocolitis (grade IV) +
B100 2.6 months Short HD, enterocolitis (grade IV) +
Details including age, diagnosis of HD and non-HD controls are shown. Patients and controls that have or have not received colos-
tomy are indicated as ‘+’ and ‘3’, respectively.
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3.2. CDX-1 and CDX-2 transcripts are co-distributed
in the colonic mucosal epithelium
To determine the tissue-speci¢c pattern of distribu-
tion of transcripts of CDX-1 and CDX-2 genes in the
colon, we ¢rst detect transcripts of CDX-1 and
CDX-2 in the distal colon of infants using RT^
PCR. CDX-1 and CDX-2 mRNAs were detected
in the colon of infants aged between 2 days and
30 months (Fig. 3). Using RT^PCR analysis, relative
levels of expression of CDX-1 and CDX-2 genes
versus L-actin was determined in colon of non-HD
infants and in patients with NEC. Ratios of
CDX-1/L-actin and CDX-2/L-actin in the colons of
non-HD infants were determined to be 0.59 þ 0.23
and 1.19 þ 0.35 (mean þ S.E.M.) respectively whereas
the ratios of CDX-1/L-actin and CDX-2/L-actin in
the colons of patients with NEC were 1.28 þ 0.24
and 0.86 þ 0.18 respectively. Relative expression lev-
els of CDX-1 and CDX-2 gene were not signi¢cantly
di¡erent between colons of non-HD infants and pa-
tients with NEC (Table 3). RT^PCR products of
CDX-1 and CDX-2 genes were cloned and nucleo-
tide sequences were determined to be identical to the
published sequences of CDX-1 and CDX-2 genes.
No ampli¢ed product was obtained in negative con-
trols in which reverse transcriptase was omitted. This
indicates that the amplicons observed in our samples
were not PCR products of the contaminating ge-
nomic DNA (data not shown).
In order to determine whether CDX-1 and CDX-2
mRNAs were con¢ned to a particular cell lineage or
compartment within the colon, in situ hybridisation
was performed in the colons of the controls. In the
distal colons of controls, CDX-1 and CDX-2 tran-
scripts were present in the mucosal epithelial cells but
not in the lamina propria or muscle layer (Fig. 4A^
D). Di¡erential distribution of CDX-1 transcript was
observed in the mucosal epithelium in which staining
was more intense in the undi¡erentiated cells at the
bottom of crypts (Fig. 4E). Unlike CDX-1, CDX-2
transcript was more evenly distributed from the bot-
tom to the tip of crypts (Fig. 4F). Sense probes of
CDX-1 and CDX-2 genes showed weak and no spe-
ci¢c background hybridisation signals (data not
shown).
Table 3
Statistical analysis of expression of CDX
CDX-1/L-actin (mean þ S.E.M.) CDX-2/L-actin (mean þ S.E.M.)
Controls (n = 7) 0.59 þ 0.23 1.19 þ 0.35
NEC (n = 5) 1.28 þ 0.24 (P = 0.08)a 0.86 þ 0.18 (P = 0.5)a
HD (n = 7)
Normoganglionic segment 0.87 þ 0.22 (P = 0.47)a 1.42 þ 0.61 (P = 0.74)a
Hypoganglionic segment 0.51 þ 0.08 (P = 0.21)b 0.75 þ 0.23 (P = 0.37)b
Aganglionic segment 0.92 þ 0.20 (P = 0.86)b 1.03 þ 0.29 (P = 0.6)b
Unpaired t-test was performed to evaluate the signi¢cance of the di¡erence of the relative expression levels of CDX-1 and CDX-2 in
controls, NEC and various segments of HD patients.
aTwo-tailed P values of the comparison of the relative expression level of CDX genes in NEC and the normoganglionic segment of
HD patients with the controls (P6 0.05 is considered to be signi¢cant).
bTwo-tailed P values of the comparison of the relative expression level of CDX genes in NEC and hypoganglionic and aganglionic
segments with normoganglionic segments of patients with HD (P6 0.05 is considered to be signi¢cant).
Fig. 3. RT^PCR analysis of CDX-1 and CDX-2 gene expres-
sions in the colons of non-HD controls and patients with NEC.
CDX-1 and CDX-2 genes are co-expressed in the colons of
non-HD control infants (A) and in patients with NEC (B).
Identity numbers of the control infants are shown above the
lanes.
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3.3. Down-regulation of CDX-1 and CDX-2 genes in
the colons of patients with HD-associated
enterocolitis
To determine whether CDX-1 and CDX-2 genes
were involved in the pathogenesis of HD-associated
enterocolitis (HDEC), we used RT^PCR to compare
the relative expression levels of CDX-1 and CDX-2
genes in the normoganglionic, hypoganglionic and
aganglionic segments of the distal colon of HD pa-
tients with and without enterocolitis using RT^PCR.
In the seven cases of HD without enterocolitis, ex-
pression levels of CDX-1 and CDX-2 genes were
similar among the three segments (Fig. 5 and data
not shown). The ratios of CDX-1/L-actin and CDX-
2/L-actin were not signi¢cantly di¡erent between the
various segments of patients with HD, Patients with
NEC, or non-HD controls (Table 3). However, in
patients with HDEC (n = 4), CDX-1 and CDX-2
gene expression levels are markedly reduced in the
aganglionic and hypoganglionic segments than in
normoganglionic segment (Fig. 5). RT^PCR bands
of CDX-1 and CDX-2 were barely detectable in hy-
poganglionic and aganglionic segments in two pa-
tients with HDEC (patient 8117 and B100; Fig. 5).
Our RT^PCR data indicated that both CDX-1 and
CDX-2 genes were down-regulated in the hypogan-
glionic and aganglionic bowels of patients with
HDEC where enterocolitis were obvious. The inten-
Fig. 5. Lower levels of expression of CDX-1 and CDX-2 in the
aganglionic colons of patients with HDEC. In panel A, repre-
sentative RT^PCR analysis results of patients with HD are
shown. CDX1 and CDX2 genes are expressed at a similar level
in di¡erent segments of patients with HD. In panel B, in pa-
tients with HDEC, expression of CDX1 and CDX2 genes is re-
duced in aganglionic (A) and hypoganglionic (H) segments
compared to their levels in the normoganglionic (N) segments
of patient’s resected colon. Identity numbers of the patients are
shown on the right.
Fig. 4. In situ hybridisation analysis of CDX-1 and CDX-2 mRNAs in the colons of normal control infants. Transcript of CDX-1
(A,B,E) is localised to the colon epithelium with strongest hybridisation signal towards the bottom of the crypts. Transcript of CDX-2
(C,D,F) is localised to colonic epithelium and is more evenly distributed from the bottom to the tip of crypts. Photographs of the hy-
bridised sections are taken under bright-¢eld illumination (A,C,E,F) or dark-¢eld illumination (B,D) to show the distribution of
CDX-1 and CDX-2 mRNAs in colons. Scale bar = 100 Wm.
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Fig. 6. In situ hybridisation analysis showed the reduction of CDX-1 and CDX-2 gene expressions in the aganglionic colon of patients
with HD. Representative in situ hybridised colon sections of patients with HD are shown. Photographs of hybridised sections of the
colon of patient 8444 are taken under dark-¢eld illumination (A^D,G^J) or bright-¢eld illumination (E,F,K,L). The level of CDX-1
transcript is lower in the aganglionic segment (B,D) than that in the normoganglionic segment (A,C). CDX-2 gene expression is
down-regulated in the aganglionic segment (H,J) compared with the normoganglionic segment (G,I). Number of silver grains for the
CDX-1 gene (E,F) and CDX-2 gene (K,L) in the mucosal epithelial cells are fewer in the aganglionic (F,L) than in the normogan-
glionic segments (E,K). Scale bars: A^D,G^J = 100 Wm; E,F,K,L = 10 Wm.
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sities of the RT^PCR bands of CDX-1 and CDX-2
genes in the hypoganglionic and aganglionic bowels
were too weak to be quanti¢ed in these two patients
with HDEC. No statistical analysis was performed
on the HDEC data because of insu⁄cient quanti¢-
cation data in the HDEC group.
In patients with HD, in situ hybridisation detected
CDX-1 and CDX-2 transcripts only in the mucosal
epithelial cells (Fig. 6). In patients with HDEC, the
levels of CDX-1 and CDX-2 gene expression in the
mucosal epithelium were lower in aganglionic seg-
ments when compared with those of normogan-
glionic segments (Fig. 6A^D,G^J). The reduced lev-
els of expression for CDX genes observed could be
due to the fact that fewer CDX expressing cells were
present in the epithelium and/or each of the epithelial
cells was expressing lower levels of CDX genes. The
intensity of silver grains on the sections was counted
under bright ¢eld illumination. As illustrated in Fig.
6, the number of silver grains derived from the CDX-
1 and CDX-2 probes found in each epithelial cell
were fewer in the aganglionic segment than in the
normoganglionic segments. This indicates that the
epithelial cells of aganglionic segments expressed
CDX-1 and CDX-2 genes at reduced levels (compare
Fig. 6E,F,K,L). Mucosal ulceration was evident in
aganglionic segments of HDEC patients (Fig. 2F)
suggesting that overall, there were fewer epithelial
cells surrounding the mucosa of aganglionic seg-
ments. Therefore, it was likely that the reductions
in expression of CDX-1 and CDX-2 genes in mu-
cosal epithelium in the aganglionic colons of patients
with HDEC were the results of fewer cells in the
mucosa; and these cells were expressing lower levels
of both CDX-1 and CDX-2 genes.
4. Discussion
The present study aims at determining whether the
homeobox genes CDX-1 and CDX-2 were involved
in HD-associated enterocolitis (HDEC). We have an-
alysed the expression of CDX-1 and CDX-2 genes in
distal colon of normal control infants as well as pa-
tients with HD. Our results show that CDX-1 and
CDX-2 genes are expressed in the mucosal epitheli-
um of distal colons of infants aged between 2 days
and 30 months. In patients with HDEC, the expres-
sion levels of CDX-1 and CDX-2 genes decrease in
the aganglionic and hypoganglionic bowels.
4.1. Reduced expression of CDX genes in
HD-associated enterocolitis
Three of our patients with HDEC who have
undergone colostomy before the pull-through proce-
dure have grade IV enterocolitis in aganglionic seg-
ments, suggesting that accumulation of stool is un-
likely to be the main factor causing local
in£ammation of intestine. Instead, other cellular ab-
normalities, probably localised in epithelial layer,
could be contributing to the susceptibility of in£am-
mation.
Intestinal mucosal epithelium is continuously re-
newed and replenished from stem cells that are lo-
cated in the intestinal crypts and give rise to absorp-
tive enterocytes, enteroendocrine cells, mucus-
secretion goblet cells and Paneth cells. Renewal and
replenishing of mucosal epithelial cells is essential for
the intestine to repair mucosa damage and prevent
bacterial infection and in£ammation. Failure to re-
new damaged mucosa could lead to an increased risk
of developing enterocolitis. Our RT^PCR analysis
revealed decreased expression of CDX genes in agan-
glionic and hypoganglionic segments in all four pa-
tients with HDEC. In situ hybridisation analysis
clearly con¢rmed that expression of CDX genes de-
creased in individual epithelial cells. Using adjacent
sections for in situ hybridisation, we have also inves-
tigated the expression of the glia cell-line derived
factor family receptor K1 (GFRA1) gene in two of
the three patients with HDEC. The GFRA1 gene
expressed in the myenteric and submucosal plexuses
of the intestine [35]. We found that the GFRA1 gene
was di¡erentially regulated in the myenteric and sub-
mucosal plexuses of hypoganglionic and aganglionic
segments in one patient with HDEC; whereas ex-
pression of GFRA1 gene was not altered in the sec-
ond patient with HDEC (V.C.H.L. and P.K.H.T.,
unpublished data). These ¢ndings con¢rmed that
the down-regulation of CDX genes in the agan-
glionic bowels of all four patients with HDEC ob-
served in this study was not due to artefacts of im-
proper tissue processing that led to RNA
degradation or general lower expression of genes in
particular sections. Unlike the case with HDEC, ¢ve
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of our controls have necrotising enterocolitis (NEC)
but did not show reduced levels of CDX transcripts.
This suggests that HDEC and NEC possess distinct
aetiologies. Our results may suggest that the de-
creased expression of CDX-1 and CDX-2 genes is
associated with the occurrence of HDEC. It has
been shown that CDX-2 regulates the expression of
cell adhesion molecules E-cadherin, integrin-L4, -L1,
L1-CAM, and extracellular matrix molecule laminin-
Q2, -K1 chain [1]. Interestingly, the migrating and
di¡erentiating cells along the crypt-villus axis show
a concomitant increasing gradient of some of these
molecules [36]. Reduced levels of expression of CDX
genes in the patients’ bowels may provoke changes in
the compositions and properties of cell adhesion
complexes and extracellular matrix (ECM) of the
mucosa. Such changes may result in defective prolif-
eration and di¡erentiation of the mucosal epithelial
cells and manifest as increased risk of in£ammation.
4.2. Hirschsprung’s disease genes and enterocolitis
In the present study, with the exception of the four
patients with HDEC, none of the patients with HD
showed reduction of CDX-1 and CDX-2 gene ex-
pression in aganglionic segments. It was shown that
homozygous Cdx-1 and heterozygous Cdx-2 knock-
out mice did not develop defect in the enteric nerv-
ous system [7^9]. Our results suggest that CDX-1
and CDX-2 genes are not directly involved in HD
and insu⁄cient levels of CDX-1 and CDX-2 is not
critical for enteric nervous system development. HD
is caused by mutations in a variety of genes including
the RET, GDNF, EDN3, EDNRB and SOX10 genes
and mutations in these genes accounted for about
20% of the patients [19], suggesting that novel HD
genes remain to be identi¢ed. Mutations of the RET
most frequently mutated gene in patients with HD,
were identi¢ed in only four out of 57 cases of spora-
dic and familial HD (7%) [37]. This suggests that HD
is a polygenic disease caused by the additive subclin-
ical e¡ects of more than one gene. Although the
genetic defects of the patients with HDEC included
in the present study are not de¢ned, it is unlikely that
they have the same genetic defect. The association of
the down-regulation of CDX genes with the occur-
rence of enterocolitis in these patients with HDEC
could be explained if the mutations of di¡erent HD
genes a¡ected the same signalling pathway for ENS
development and the regulation of CDX genes ex-
pression. Mutations of such HD genes in these pa-
tients with HDEC caused defects in the same signal-
ling pathway and resulted in colonic aganglionosis
and down-regulation of CDX-1 and CDX-2 genes
as well as increased risk of developing enterocolitis
in these HDEC patients. Piebald-lethal mouse, a
mouse model of HD, has missense mutations in the
ednrb genes and frequently develops systemic sepsis
caused by enteric organism [28,29]. It has been
postulated that the systemic sepsis in piebald-lethal
mouse is the consequence of the loss of mucosal
barrier integrity in the distal aganglionic bowel.
Our present ¢ndings suggest that the loss of mucosal
integrity may represent a critical and common event
in the aetiology of HDEC. Further study of the ex-
pressions of CDX genes in patients with HDEC is
essential to determine whether the down-regulation
of CDX-1 and CDX-2 genes is a common mecha-
nism in all HDEC.
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